https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Provision of chronic disease preventive care in community substance use services: client and clinician report https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24226 Wed 23 Feb 2022 16:06:15 AEDT ]]> Is folic acid the ultimate functional food component for disease prevention? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1900 Wed 11 Apr 2018 11:39:12 AEST ]]> Feasibility of a GP delivered skin cancer prevention intervention in Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16759 Wed 11 Apr 2018 11:34:14 AEST ]]> Likelihood of obesity in early and late childhood based on growth trajectory during infancy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53683 Wed 10 Jan 2024 10:27:44 AEDT ]]> The provision of preventive care for modifiable health risk behaviours by clinicians within substance use treatment settings: a systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36387 Wed 07 Apr 2021 20:17:14 AEST ]]> Does male circumcision reduce women's risk of sexually transmitted infections, cervical cancer, and associated conditions? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38594 Trichomonas vaginalis, bacterial vaginosis and possibly genital ulcer disease. For herpes simplex virus type 2, Chlamydia trachomatis, Treponema pallidum, human immunodeficiency virus and candidiasis, the evidence is mixed. Male partner MC did not reduce risk of gonorrhea, Mycoplasma genitalium, dysuria or vaginal discharge in women. Conclusion: MC reduces risk of oncogenic HPV genotypes, cervical cancer, T. vaginalis, bacterial vaginosis and possibly genital ulcer disease in women. The reduction in risk of these STIs and cervical cancer adds to the data supporting global efforts to deploy MC as a health-promoting and life-saving public health measure and supplements other STI prevention strategies.]]> Tue 16 Nov 2021 15:04:36 AEDT ]]> The power of genetic diversity in genome-wide association studies of lipids https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48599 Tue 04 Apr 2023 19:22:25 AEST ]]> Effectiveness of meatal cleaning in the prevention of catheter-associated urinary tract infections and bacteriuria: An updated systematic review and meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40311 Thu 07 Jul 2022 17:03:37 AEST ]]> Interactional skills of students from traditional and non-traditional medical schools before and after alcohol education https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1376 Sat 24 Mar 2018 08:28:18 AEDT ]]> Ten citation classics from the Australian and New Zealand Journal of Public Health (editorial) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4778 Sat 24 Mar 2018 07:20:45 AEDT ]]> Factors associated with neck pain in fighter aircrew: A systematic review and meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39686 Fri 17 Jun 2022 15:46:20 AEST ]]> Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: An observational study using active surveillance https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49361 Fri 12 May 2023 12:35:08 AEST ]]> Surveillance is the first step to preventing injury among fast jet aircrew: results of a 2-year prospective cohort study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55250 Fri 03 May 2024 09:25:25 AEST ]]> Single dose v two-dose antenatal anti-D prophylaxis: a randomised controlled trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46858 P < 0.001). Compliance was not significantly different between the single dose (86 of 138, 61%) and two‐dose groups (70 of 139, 50%; P = 0.06). Conclusions: The two‐dose RAADP schedule currently recommended in Australia provides better protection against Rh(D) sensitisation than a one‐dose regimen. Trial registration: Australian and New Zealand Clinical Trials Registry (ACTRN12613000661774).]]> Fri 02 Dec 2022 11:01:30 AEDT ]]>